74.50 0.00 (0.00%)
After hours: 4:51PM EST
|Bid||74.25 x 800|
|Ask||74.80 x 1200|
|Day's Range||74.13 - 75.67|
|52 Week Range||60.14 - 83.88|
|Beta (3Y Monthly)||1.03|
|PE Ratio (TTM)||24.50|
|Earnings Date||Feb 6, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||2.00 (2.70%)|
|1y Target Est||93.00|
Dividend growth stocks have obvious appeal. After all, dividend investing is based on buying and holding a stock for the payouts. Unlike traditional growth investing, where you depend on a stock increasing in value based on profits or sales trends, dividend investing focuses on the payouts above all else.
CVS Health (CVS) estimates a $750-million earning from near-term synergies with low- to mid-single digit addition in the second year after the closure of Aetna transaction.
CVS Health acquired health insurance giant Aetna for about $70 billion. CVS has bought other pharmacies to build its footrprint, as well as pharmacy benefit manager Caremark and walk-in health clinic MinuteClinic. It's buying a health insurer to prove it.
To start 2018, many on Wall Street were predicting a great year for stocks, as Donald Trump's tax plan was expected to produce elevated mergers and acquisitions activity. The deal activity has certainly been a part of the 2018 story, but the trend could slow down in 2019, said analysts from Goldman Sachs. Deal announcements are expected to increase 20% year over year in 2018, according to a note from Goldman that was released Tuesday.
The latest list of new buys by the best mutual funds shows a focus on large cap stocks like Berkshire, led by Warren Buffett, CVS, Starbucks and Adobe.
Is CVS Health Corporation (NYSE:CVS) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from industry insiders. They sometimes fail miserably but historically their consensus stock picks outperformed the market […]
Walgreens Boots Alliance Inc. has teamed up with FedEx Corp. to launch a nationwide next-day prescription home-delivery service as the drugstore chain works to stave off competition from Amazon.com Inc. and other rivals. Under the delivery service called Walgreens Express, patients enrolled in text alerts will receive text notification when qualifying prescriptions are ready, Walgreens said Thursday. For a $4.99 fee, patients can have their prescriptions delivered by FedEx to their home as early as the next day.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain. Rival CVS Health Corp launched its own next-day delivery service earlier this year.
Walgreens is joining rival drugstore chain CVS Health in expanding home deliveries for prescriptions nationwide, as stores continue adjusting to a retail world made more consumer-friendly by online competition. Walgreens said Thursday it will partner with FedEx to deliver prescriptions as soon as the next day for a $4.99 fee, and it also is providing same-day deliveries in several cities including New York, Chicago and Dallas. Walgreens and FedEx Corp. began a partnership last year where the drugstore chain started offering package drop-off and pick-up services at several thousand stores.
Walgreens Boots Alliance said on Thursday it would partner with FedEx Corp to launch a next-day delivery service for prescription drugs nationwide, giving it a leg up as Amazon threatens to shake-up the sector. In the race to make inroads in the on-demand drug delivery space, Walgreens' move could potentially put it head-to-head with Amazon.com Inc, which earlier this year said it would buy online pharmacy PillPack. Amazon's entry in the market would rattle traditional drug retailers and could potentially disrupt major players the U.S. drug supply chain.
The company announced a new pricing model for its pharmacy benefit management services Wednesday morning. The White House has been an active critic of PBMs, which negotiate drug discounts on behalf of employers and health plans, arguing that they have distorted the drug-pricing system. Drugmakers pay rebates than can amount to more than 50 percent of a drug’s sticker price to secure favorable coverage on PBM drug lists, and critics contend that firms like CVS keep an excessive slice of those undisclosed payments.
Ryan McQueeney discusses the latest drama in the U.S.-China trade war, new developments in Les Moonves' departure from CBS, and a new drug pricing plan from pharmacy giant CVS.
"There's a way to get all of that digitally on your phone," along with the coupons and extra bucks rewards, CVS CEO Larry Merlo tells CNBC's Bertha Coombs.
CVS Health Corp. announced Wednesday that CVS Caremark, its prescription benefit management (PBM) subsidiary, will be rolling out a new model of pricing it says will offer greater "drug cost predictability and pricing simplicity." Under the model, CVS plans to pass through 100% of drug rebates to its health plan clients and says it will be accountable for the impact of drug price inflation and shifts in drug mix. CVS, which completed its $69 billion acquisition of health insurer Aetna last week, said it would begin rolling out the new model starting in 2019. PBMs and the rebates they receive from drug companies have come under increasing scrutiny and criticism in the past two years, with policymakers and clients calling for greater transparency of their financial arrangements. Shares of CVS have increased 8.8% in the year to date, while the S&P 500 has gained 1%.
The "guaranteed net cost" option could also deflect growing criticism that pharmacy benefit managers (PBMs) reap gains off the widening gap between pharmaceutical list prices and their lower net cost after hefty rebates paid by drugmakers to secure coverage and access to their products. President Donald Trump, who has promised lower prescription drug costs for U.S. consumers, earlier this year singled out industry "middlemen", such as PBMs and insurers, and the common practice of drugmakers offering rebates to them.
Guaranteed Net Cost model offers drug cost predictability and pricing simplicity, enabling clients to maximize the impact of PBM cost management strategies Under new model, 100 percent of rebates are passed ...
** A federal judge who has been asked to sign off on the U.S. government's decision to approve CVS Health Corp's acquisition of insurer Aetna Inc said he was "less convinced" than the government that the companies had struck a deal that ensured the merger was legal under antitrust law. ** Debt-laden Indian carrier Jet Airways Ltd is close to finalising a deal under which shareholder Etihad Airways will inject fresh funds, news channel CNBC-TV18 reported, citing sources. ** U.S. oil and gas company Chevron has decided to launch the sale of its stake in Azerbaijan's largest oil field as well as the Baku-Tbilisi-Ceyhan (BTC) pipeline, it said in a statement.